Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Empagliflozin on Serum Sodium in Acute Heart Failure with Hyponatremia
TCTR20241012013Phase 3Recruiting
- Sponsor
- Thammasat University Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in Acute Heart Failure (AHF), hyponatraemia, sponsored by Thammasat University Hospital. Started Sep 2024; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
Acute Heart Failure (AHF)hyponatraemia
Beyond the preview
Go deeper on TCTR20241012013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241012013.